Moving the back of the eye to the forefrontof research and development.
Learn more about our goals »
Providing the diabetic patient with a low-drug exposure, sustained-release treatment for Diabetic Macular Edema.
Learn more about how ILUVIEN works »
Diabetes is the leading cause of new cases of blindness in adults.
Learn how Alimera Sciences is creating reliable, effective treatments for diabetic retinopathy »
View All Recent News »
November 11, 2011 -- Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has received a complete response letter...
Read More »
November 07, 2011 -- Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that management will be attending the following...
November 03, 2011 -- Alimera Sciences, Inc. ...